
The Cigna Group: updates and filings
Price
$297.00
November 13, 2026Market cap $78.3B
What Ploutos Investor adds for Cigna
Part of Ploutos Investor, €9.99 a month
- The full history: 10 fiscal years, from 2016
- The estimated fair value, with its range and its certainty
- The full analysis, 18 a month
- More questions to the chat on its filings
- Excel with every year
- An email when it reports, changes its dividend or an officer buys
Sign in with a free account to see the last 5 fiscal years.
What comes next, and what happened
Its next results and latest dividend, and the filings that told of something: results, deals, people, debt. In plain words, each linked to the filing.
Next results
last Nov 5, 2026next Feb 4, 2027
The date the company itself announced on its investor site. The announcement
November 2026
October 2026
July 2026
April 2026
February 2026
November 2025
Its SEC filings
What it has filed lately, newest first, linked to the document itself.
- Nov 5, 2026Quarterly reportfor the period to Sep 30, 2026Form10-Q
- Nov 5, 2026Results of operationsForm8-K
- Oct 9, 2026Officer or director changeForm8-K
- Sep 30, 2026Regulation FD disclosureForm8-K
- Jul 30, 2026Quarterly reportfor the period to Jun 30, 2026Form10-Q
- Jul 30, 2026Results of operationsForm8-K
- Jun 24, 2026Employee stock plan reportfor the period to Dec 31, 2025Form11-K
- May 13, 2026Regulation FD disclosureForm8-K
- Apr 30, 2026Quarterly reportfor the period to Mar 31, 2026Form10-Q
- Apr 30, 2026Results of operationsForm8-K
- Apr 29, 2026Over-5% holder statement (passive)FormSCHEDULE 13G
- Apr 27, 2026Shareholder voteForm8-K
- Mar 26, 2026Over-5% holder statement (passive) (amendment)FormSCHEDULE 13G/A
- Mar 13, 2026Annual report to shareholdersfor the period to Dec 31, 2025FormARS
- Mar 13, 2026Additional annual meeting materialFormDEFA14A
- Mar 13, 2026Annual meeting proxy statementFormDEF 14A
- Mar 5, 2026Over-5% holder statement (passive) (amendment)FormSCHEDULE 13G/A
- Mar 3, 2026Officer or director change, Regulation FD disclosureForm8-K
- Feb 27, 2026Regulation FD disclosureForm8-K
- Feb 26, 2026Annual reportfor the period to Dec 31, 2025Form10-K
- Feb 5, 2026Results of operationsForm8-K
- Nov 18, 2025Other material eventsForm8-K
- Nov 5, 2025Over-5% holder statement (passive) (amendment)FormSCHEDULE 13G/A
- Oct 30, 2025Quarterly reportfor the period to Sep 30, 2025Form10-Q
- Oct 30, 2025Results of operationsForm8-K
| Filed | Form | What it is | Filing |
|---|---|---|---|
| Nov 5, 2026 | 10-Q | Quarterly reportfor the period to Sep 30, 2026 | Document |
| Nov 5, 2026 | 8-K | Results of operations | Document |
| Oct 9, 2026 | 8-K | Officer or director change | Document |
| Sep 30, 2026 | 8-K | Regulation FD disclosure | Document |
| Jul 30, 2026 | 10-Q | Quarterly reportfor the period to Jun 30, 2026 | Document |
| Jul 30, 2026 | 8-K | Results of operations | Document |
| Jun 24, 2026 | 11-K | Employee stock plan reportfor the period to Dec 31, 2025 | Document |
| May 13, 2026 | 8-K | Regulation FD disclosure | Document |
| Apr 30, 2026 | 10-Q | Quarterly reportfor the period to Mar 31, 2026 | Document |
| Apr 30, 2026 | 8-K | Results of operations | Document |
| Apr 29, 2026 | SCHEDULE 13G | Over-5% holder statement (passive) | Document |
| Apr 27, 2026 | 8-K | Shareholder vote | Document |
| Mar 26, 2026 | SCHEDULE 13G/A | Over-5% holder statement (passive) (amendment) | Document |
| Mar 13, 2026 | ARS | Annual report to shareholdersfor the period to Dec 31, 2025 | Document |
| Mar 13, 2026 | DEFA14A | Additional annual meeting material | Document |
| Mar 13, 2026 | DEF 14A | Annual meeting proxy statement | Document |
| Mar 5, 2026 | SCHEDULE 13G/A | Over-5% holder statement (passive) (amendment) | Document |
| Mar 3, 2026 | 8-K | Officer or director change, Regulation FD disclosure | Document |
| Feb 27, 2026 | 8-K | Regulation FD disclosure | Document |
| Feb 26, 2026 | 10-K | Annual reportfor the period to Dec 31, 2025 | Document |
| Feb 5, 2026 | 8-K | Results of operations | Document |
| Nov 18, 2025 | 8-K | Other material events | Document |
| Nov 5, 2025 | SCHEDULE 13G/A | Over-5% holder statement (passive) (amendment) | Document |
| Oct 30, 2025 | 10-Q | Quarterly reportfor the period to Sep 30, 2025 | Document |
| Oct 30, 2025 | 8-K | Results of operations | Document |
From the company's record at the SEC (EDGAR). The topics of each 8-K are the item codes the company itself filed. Its whole record at the SEC, since May 16, 2018.
The full analysis
What do Cigna's filings show?
The filings are where every one of Cigna's figures comes from. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.
- A fair value range built from the filings
- Earnings quality, debt and red flags
- Insider and institutional moves
- The case for and the case against
Related pages
The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.
The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.